Your request to link to rcsb for Interleukin-1 receptor-associated kinase 4

---

• 1WH4: solution structure of the death domain of interleukin-1 receptor-associated kinase4 (irak4) from mus musculus
• 2A9I: molecular structure of the interleukin-1 receptor- associated kinase-4 death domain
• 2NRU: crystal structure of irak-4 (10.1016/J.STR.2006.11.001 )
• 2NRY: crystal structure of irak-4 (10.1016/J.STR.2006.11.001 )
• 2O8Y: apo irak4 kinase domain
• 2OIB: crystal structure of irak4 kinase domain apo form
• 2OIC: crystal structure of irak4 kinase domain complexed with staurosporine
• 2OID: crystal structure of irak4 kinase domain complexed with amppnp
• 3MOP: the ternary death domain complex of myd88, irak4, and irak2 (10.1038/NATURE09121 )
• 4RMZ: crystal structure of irak-4
• 4U97: crystal structure of asymmetric irak4 dimer (10.1016/J.MOLCEL.2014.08.006 )
• 4U9A: sulphur anomalous crystal structure of asymmetric irak4 dimer (10.1016/J.MOLCEL.2014.08.006 )
• 4XS2: irak4-inhibitor co-structure (10.1016/J.BMCL.2015.03.043 )
• 4Y73: crystal structure of irak4 kinase domain with inhibitor (10.1021/ACSMEDCHEMLETT.5B00107 )
• 4YO6: irak4-inhibitor co-structure (10.1021/ACSMEDCHEMLETT.5B00106 )
• 4YP8: irak4-inhibitor co-structure (10.1021/ACSMEDCHEMLETT.5B00106 )
• 4ZTL: irak4-inhibitor co-structure (10.1021/ACSMEDCHEMLETT.5B00279 )
• 4ZTM: irak4-inhibitor co-structure (10.1021/ACSMEDCHEMLETT.5B00279 )
• 4ZTN: irak4-inhibitor co-structure (10.1021/ACSMEDCHEMLETT.5B00279 )
• 5K72: irak4 in complex with compound 21 (10.1021/ACS.JMEDCHEM.7B01290 )
• 5K75: irak4 in complex with compound 1 (10.1021/ACS.JMEDCHEM.7B01290 )
• 5K76: irak4 in complex with compound 28 (10.1021/ACS.JMEDCHEM.7B01290 )
• 5K7G: irak4 in complex with az3862 (10.1021/ACS.JMEDCHEM.7B01290 )
• 5K7I: irak4 in complex with az3864 (10.1021/ACS.JMEDCHEM.7B01290 )
• 5KX7: irak4-inhibitor co-structure (10.1016/J.BMCL.2016.07.048 )
• 5KX8: irak4-inhibitor co-structure (10.1016/J.BMCL.2016.07.048 )
• 5T1S: irak4 kinase - compound 1 co-structure (10.1016/J.BMCL.2017.04.050 )
• 5T1T: irak4 kinase - compound 1 co-structure (10.1016/J.BMCL.2017.04.050 )
• 5UIQ: crystal structure of irak4 in complex with compound 9 (10.1021/ACS.JMEDCHEM.7B00231 )
• 5UIR: crystal structure of irak4 in complex with compound 11 (10.1021/ACS.JMEDCHEM.7B00231 )
• 5UIS: crystal structure of irak4 in complex with compound 12 (10.1021/ACS.JMEDCHEM.7B00231 )
• 5UIT: crystal structure of irak4 in complex with compound 14 (10.1021/ACS.JMEDCHEM.7B00231 )
• 5UIU: crystal structure of irak4 in complex with compound 30 (10.1021/ACS.JMEDCHEM.7B00231 )
• 5W84: crystal structure of irak-4 with a 4,6-diaminonicotinamide inhibitor (compound number 4) (10.1016/J.BMCL.2017.09.029 )
• 5W85: crystal structure of irak-4 with a 4,6-diaminonicotinamide inhibitor (compound number 9) (10.1016/J.BMCL.2017.09.029 )
• 6EG9: irak4 in complex with ponatinib (10.1074/JBC.RA118.005428 )
• 6EGA: irak4 in complex with a type ii inhibitor (10.1074/JBC.RA118.005428 )
• 6EGD: crystal structure of the unphosphorylated irak4 kinase domain bound to a type i inhibitor (10.1074/JBC.RA118.005428 )
• 6EGE: crystal structure of the unphosphorylated irak4 kinase domain bound to a type i inhibitor (10.1074/JBC.RA118.005428 )
• 6EGF: crystal structure of the inactive unphosphorylated irak4 kinase domain bound to amp-pnp (10.1074/JBC.RA118.005428 )
• 6F3D: irak4 in complex with inhibitor (10.1016/J.BMC.2018.01.008 )
• 6F3E: irak4 in complex with inhibitor (10.1016/J.BMC.2018.01.008 )
• 6F3G: irak4 in complex with inhibitor (10.1016/J.BMC.2018.01.008 )
• 6F3I: irak4 in complex with inhibitor (10.1016/J.BMC.2018.01.008 )
• 6LXY: irak4 in complex with inhibitor (10.1021/ACSMEDCHEMLETT.0C00082 )
• 6MOM: crystal structure of human interleukin-1 receptor associated kinase 4 (irak 4, cid 100300) in complex with compound ncc00371481 (bsi 107591) (10.1126/SCITRANSLMED.AAW8828 )
• 6N8G: irak4 bound to benzoxazole compound
• 6O8U: crystal structure of irak4 in complex with compound 23 (10.1021/ACS.JMEDCHEM.9B00439 )
• 6O94: structure of the irak4 kinase domain with compound 17 (10.1021/ACS.JMEDCHEM.9B00439 )
• 6O95: structure of the irak4 kinase domain with compound 41 (10.1021/ACS.JMEDCHEM.9B00439 )
• 6O9D: structure of the irak4 kinase domain with compound 5 (10.1021/ACS.JMEDCHEM.9B00439 )
• 6RFI: irak4 in complex with inhibitor (10.1021/ACS.JMEDCHEM.9B01346 )
• 6RFJ: irak4 in complex with inhibitor (10.1021/ACS.JMEDCHEM.9B01346 )
• 6THW: irak4 in complex with inhibitor (10.1016/J.BMC.2020.115815 )
• 6THX: irak4 in complex with inhibitor (10.1016/J.BMC.2020.115815 )
• 6THZ: irak4 in complex with inhibitor (10.1016/J.BMC.2020.115815 )
• 6TI8: irak4 in complex with inhibitor (10.1016/J.BMC.2020.115815 )
• 6TIA: irak4 in complex with inhibitor (10.1016/J.BMC.2020.115815 )
• 6UYA: crystal structure of compound 19 bound to irak4 (10.1021/ACSMEDCHEMLETT.9B00380 )
• 6VQL: crystal structure of interleukin-1 receptor-associated kinase 4 (irak4-wt) complex with a nicotinamide inhibitor (10.1021/ACSMEDCHEMLETT.0C00082 )
• 7C2V: crystal structure of irak4 kinase in complex with the inhibitor ca- 4948 (10.1021/ACSMEDCHEMLETT.0C00255 )
• 7C2W: crystal structure of irak4 kinase in complex with a small molecule inhibitor (10.1021/ACSMEDCHEMLETT.0C00255 )